Our Products

PREON logo

OmicsChart PREON is a patient-centric cancer data and analytics platform for translational cancer biologists. The goal of the platform is to enable researchers to gain deeper insights into patient populations by aggregating data from different sources. PREON contains over 24,000 de-identified cancer patient records from public and proprietary data providers.

Validate your findings using real-world data (RWD) and perform biomarker discovery and analytics.

DNA strand

Explore target of interest in 24,000+ patients

Network analysis

Perform complex bioinformatics analytics

Target board with arrow

Get actionable insights about your target

Software screenshot

Patient Cohort Builder

Search data using our innovative cohort browser by data type, treatment and create custom cohorts.

OmicsChart PREON contains curated data from real-world cancer patients from public and propriety data. With more data integrations from public repositories and commercial providers planned. Simply search and save patient group.

Software screenshot

Genomic Biomarker Analytics

Perform biomarker discovery within and across data sources.

Characterise both patient group and biomarker/target with OmicsChart PREON. Explore RNA expression, Tumour Mutational Burden (TMB), Total Tumour mRNA and Homologous Recombinant Deficiency. Perform correlation between 2 biomarkers, browse top 50 mutated genes and perform survival analysis. And finally compare biomarkers and their expression across multiple groups in primary, metastatic and recurrent tumours all in one platform.

Software screenshot

Results & Reports Workspace

Review your analysis results in a secure, interactive environment.

Whether through custom analytics, biomarker discovery projects, or real-world data validation, all deliverables from our team are shared via the PREON platform. Access visual reports, cohort summaries, genomic signatures, and track ongoing service work — all in one place. Collaborate with our experts directly inside the platform for faster insights and smoother handoffs.